Fundviser Capital (India) Limited (BOM:530197)
355.00
-2.70 (-0.75%)
At close: Jun 17, 2026
Fundviser Capital (India) Revenue
In the fiscal year ending March 31, 2026, Fundviser Capital (India) had annual revenue of 1.24B INR with 272.43% growth. Fundviser Capital (India) had revenue of 133.01M in the quarter ending March 31, 2026, a decrease of -49.98%.
Revenue
1.24B
Revenue Growth
+272.43%
P/S Ratio
1.69
Revenue / Employee
206.60M
Employees
6
Market Cap
2.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.24B | 906.75M | 272.43% |
| Mar 31, 2025 | 332.84M | 323.11M | 3,318.32% |
| Mar 31, 2024 | 9.74M | 7.52M | 339.51% |
| Mar 31, 2023 | 2.22M | 500.40K | 29.18% |
| Mar 31, 2022 | 1.72M | -6.62M | -79.43% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Eraaya Lifespaces | 25.68B |
| Modern Engineering and Projects | 1.23B |
| ASL Industries | 1.04B |
| Kabra Drugs | 927.40M |
| Transchem | 92.61M |
| IB Infotech Enterprises | 71.32M |
| Maha Rashtra Apex Corporation | 47.41M |
| ZR2 Bioenergy | 18.68M |